Yiguo Hu1, Yuhua Liu1, Shawn Pelletier1, Elisabeth Buchdunger2, Markus Warmuth3, 5, Doriano Fabbro2, Michael Hallek3, 5, Richard A Van Etten4
& Shaoguang Li11
The Jackson Laboratory, 600 Main St., Bar Harbor, Maine
04609, USA.
2
Novartis Pharma AG, 4002
Basel, Switzerland.
3
Medizinische Klinik III, Universitat München, München, Germany.
4
Molecular Oncology Research Institute, Tufts-New England Medical Center, 750 Washington St., Boston, Massachusetts
02111, USA.
5
Present addresses: Genetics Institute of the Novartis Research Foundation, San Diego, California
92121, USA (M.W.); Klinik I fur Innere Medizin, Universitat zu Koln, Joseph-Stelzmann Str. 9, 50924
Koln, Germany (M.H.).
Correspondence should be addressed to Shaoguang Li sli@jax.org
